Journal of Natural Products · 1999 · 37 citations · 3 references
Life SciencesBiochemistryPharmacologyDrug DiscoveryLipid BiochemistryMembrane BiochemistryCholesterol BiosynthesisCholesterol MetabolismLipid BiosynthesisLipid MetabolismMarine Bioactive CompoundsMarine Natural ProductsBioactive Compounds From Marine SpongesBioactive Marine MetabolitesMarine LipidsMarine Sponge MetabolitesMarine-derived Drug DiscoveryMarine-derived Enzyme InhibitorsPharmacological Inhibition Of Cholesterol BiosynthesisSponges As Drug Sources
A series of phospholipids, including previously undescribed compounds 4-7, were isolated by a bioactivity-guided fractionation from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis in human liver cells. These compounds were identified as lyso-PAF analogues (1-5) and lysophosphatidylcholines (6, 7) based on NMR and MS analyses. Compounds 1-7 specifically blocked the conversion of lanosterol into cholesterol in the Chang liver cell.
3
Kimiko Murakami‐Murofushi, M. Shioda, Kazuhiko Kaji et al. · Journal of Biological Chemistry · 1992 · 90 citations · Full text
Nicolas Gerst, Albert Duriatti, Francis Schuber et al. · Biochemical Pharmacology · 1988 · 30 citations